Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) Cashflow Statement

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Swedish Orphan Biovitrum AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

    2021
    December 31st
    C2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSInterim ReportARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,2953,3212,9544,40734
    Depreciation
    Non-Cash Items5033161,040845974
    Other Non-Cash Items
    Changes in Working Capital-334-1,480-2,724-1,543-2,539
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities5,4704,5764,4707,3888,565
    Capital Expenditures-370-1,477-4,943-3,005-3,153
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items3—-16,961-86-1,141
    Acquisition of Business
    Sale of Fixed Assets
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-367-1,477-21,904-3,091-4,294
    Financing Cash Flow Items-351-438-203178555
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-4,474-2,90217,012-4,001-4,323
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash641316-457235-98